GW Pharma Ending The Year On A High Note
Cannabinoid drug developer GW Pharmaceuticals PLC- ADR GWPH 2.65% is ending an eventful 2016 on a high note. Shares were surging higher by 6.6 percent on Monday following new drug data out over the weekend and a strong fiscal Q4 earnings report out Monday.